The Future of Personalized Medicine for Mental Illness
Newly appointed Chief Innovation Officer of M2Bio Sciences, Dr. Riyad Domingo, presenting his inaugural webinar on the future of mental health therapeutics derived from the psychedelic prodrug psilocybin. 🍄
Providing an overview of the company's innovative work leveraging the power of artificial intelligence and additive manufacturing in the drug discovery and development process. 🧪🔬
Welcome to the future of personalized medicine for mental illness.
For more information visit: https://m2bio.co/